DRUGS ACTING ON THE IMMUNE SYSTEM Flashcards

1
Q
  • decreasing virus level to an undetectable levels
  • preserving and increasing the number of CD4+ T cells
  • preventing resistant
  • having client in good clinical condition
  • preventing secondary infections and cancers
A

HAART - highly active antiretroviral therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  • reduce the detectable viral load of HIV RNA as low as possible
  • maintain this level of suppression for as long as possible
  • prevent opportunistic infections
A

antiretroviral therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  • force the HIV virus to use faulty versions of building blocks so infected cells cant make more HIV
A

NRTIs - nucleoside/tide reverse transcriptase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  • also called “non-nukes”
  • they bind to a specific protein so the HIV virus cant make copies of itself
A

NNRTIs - non-nucleoside reverse transcriptase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  • these drugs block a protein that infected cells need to put together new HIV virus particles
A

PIs - protease inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  • these stop HIV from making copies of itself by blocking a key protein that allows the virus to put its DNA into healthy cell’s DNA
A

integrase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • unlike NRTIs, NNRTIs, PIs, and INSTIs, which work on infected cells, these drugs block HIV from getting inside healthy cells
A

fusion inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • new class of drug with just on medication, fostemsavir
  • for adults who have tried multiple HIV meds and whose HIV has been resistant to other therapies
  • targets the glycoprotein 120 on the virus surface
  • stops it from being able to attach itself to the CD4 T-cells
A

gp120 attachment inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • maraviroc or MVC
  • stops HIV before it gets inside a healthy cell, but in a different way than FIs
  • blocks a specific kind of hook on the outside of certain cells so the virus cant plug in
A

CCR5 antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • new class of antiviral medication specifically for adults living with HIV who have tried multiple HIV medications and whose HIV has been resistant to other therapies
  • ibalizumad-uiyk blocks your body’s HIV infected cells from spreading the virus into those which are uninfected
A

post-attachment inhibitor / monoclonal antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pharmacologic enhancers are also called ___

A

drug boosters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

___, taken in a low dose, increases blood levels of lopinavir (LPV) and the drug LPV/r

A

ritonavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

some manufacturers put together specific medicines into a single pill so theyre easier to take

A

fixed-dose combinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

you takes these meds before HIV gets into your system to help protect against infection

A

PrEP - pre-exposure prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HIV medicines taken very soon after a possible exposure to HIV to prevent the virus from taking hold in your body

A

PEP - post exposure prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how many hours should you start PEP after possible exposure?

A

72 hours (3 days)

17
Q

if you are prescribed PEP, you need to take HIV meds every day for ___ days

A

28

18
Q
  • pathogen invades the body
  • produce antibodies (immunoglobulins)
A

active immunity

19
Q

determined in a specific population

A

natural immunity

20
Q

exposure to an antigen or from passive injection of immunoglobulins

A

acquired immunity

21
Q
  • 0-11 mos
  • 1 dose
  • 0.5 cc, intradermal at R arm
  • may cause scar
A

BCG - bacillus calmette guerine

22
Q
  • 6 weeks
  • 3 doses / 4 weeks interval
  • 0.5 cc, intramuscular, outer thigh
  • slight fever
A

DPT - diptheria, pertussis, tetani

23
Q
  • 6 weeks
  • 3 doses / 4 weeks interval
  • 2-3 gtts, oral
  • do not feed after 30 mins
A

OPV - oral polio vaccine

24
Q
  • at birth
  • 3 doses
  • 0.5 cc, intramuscular, outer thighs
  • not given to children > 10
A

hepatitis B

25
Q
  • 9 months
  • 1 dose
  • 0.5 cc,, subcutaneous, R arm
  • pain on injection site
A

measles

26
Q
  • as early as possible during pregnancy
  • 5 doses OR 2 doses with DPT
  • 0.5 cc, intramuscular, deltoid
A

tetanus toxoid